HEMP FOR VICTORY ACT

Since the passage of the 2018 Farm Bill, which removed hemp from the Controlled Substances Act, there has been a growing interest to capitalize on hemp cultivation across the United States. As a commercial, industrial, and medicinal/therapeutic product,
the potential for hemp to become a major U.S. commodity already is evident given continued expansion of hemp cultivation in states and their businesses.

Read More

Marijuana Data Collection Act

Several studies by prominent healthcare associations and scientific publications have produced data that analyzes states that have legalized marijuana and the benefits legalization has produced for the state from an economic, criminal justice, and healthcare
perspective, among others. Despite these reports, marijuana remains a controversial topic, fueled by its misplaced stigma, and the “war on drugs” rhetoric from various prominent law enforcement officials. While President Trump stood by his original position
to allow states to continue their programs without federal interference, authorizing legislation to deschedule, or allow research for medical and/or non-medicinal marijuana, has yet to advance in Congress.

Read More

Support Bipartisan Marijuana Descheduling Legislation

Even though 33 states and D.C. have legalized medical marijuana, 11 states and D.C. have legalized adult-use marijuana, and 68 percent of Americans support legalization, marijuana is still listed under Schedule 1 of the Controlled Substances Act. Enforcing
federal prohibition of marijuana will only serve to increase incarcerations, prevent invaluable research into its medicinal benefits, and create financial barriers for businesses.

Read More